CD147 plays a role in SARS-CoV infection which is blocked by the CD147 AP-9 antagonist peptide and by a humanized antibody against CD147 developed in-house (Meplazumab) (Wang et al., 2020c). The gene discussed is BSG; the disease is severe acute respiratory syndrome.